Vaisala acquires Veriteq
Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments Inc, a continuous monitoring system and data logger company based in Canada.
Veriteq is a provider of productised continuous monitoring systems and data logger solutions for the life science industry comprising pharmaceutical, biotechnological and medical device companies.
Life science is a focus area for Vaisala's Controlled Environments business, and the acquisition of Veriteq, with its life science emphasis, aligns with Vaisala's strategy.
"Vaisala is currently known as an instrument provider in the global pharmaceutical market. We want to strengthen our position by expanding our offering both to pharmaceutical and other life science customers. The Veriteq acquisition is a major step towards this goal, bringing additional know-how, a customer base, products and services to Vaisala," says Pirjo Kortteisto, Director of Cleanrooms and Chambers market segment.
Nominations now open for the 2026 NMI Measurement Awards
Until 20 May, the National Measurement Institute (NMI) is accepting nominations for the 2026 NMI...
Australia to begin treaty negotiations on association to Horizon Europe
To give Australian organisations access to the world's largest pooled research fund in 2027,...
Vaxxas partners with AI company Profenso to support quality assurance
A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in...
